Rockwell Medical (RMTI) M&A announcement summary

Deal rationale and strategic fit

• Vantive’s global HD business adds concentrates, AK 98 machines, water systems, consumables, dry concentrate cartridges, parts and technical services, broadening the portfolio into a vertically integrated global platform.

• The acquisition shifts the business from a primarily U.S. concentrates focus to broader international manufacturing, distribution and recurring aftermarket revenue.

• The ~100,000-machine installed base is expected to support recurring demand for consumables, replacement parts and services; combined annual revenue is projected at $400 million-$450 million, with ~90% recurring.

• Complementary products, customer relationships, distribution and technical capabilities are intended to strengthen service to dialysis providers and patients.

Financial terms and conditions

• Base purchase price is $125 million, subject to customary adjustments, financed by two $50 million six-year term loans and a $25 million convertible note from Vantive.

• Tranche A and B start at SOFR + 550 bps and SOFR + 700 bps, respectively, increasing 75 bps annually; neither has prepayment penalties.

• The convertible note’s initial conversion price is set at a 100% premium to the common stock’s 15-day VWAP; up to $45 million in contingent consideration is tied to revenue and EBITDA milestones.

• Previously issued 2026 guidance for net sales, gross margin, adjusted EBITDA and operating cash flow was withdrawn due to expected transaction- and financing-related expenses.

Synergies and expected cost savings

• Acquired products have margins similar to the existing business, with management citing potential upside after assuming operations.

• Cross-selling Vantive products to the existing U.S. customer base was identified as a significant growth opportunity; no estimate was provided.

• Combining the Medolla campus with automated U.S. concentrate lines is expected to improve manufacturing scale, efficiency and global supplier competitiveness.